Actuarial Notes

Managing and Evaluating Healthcare Intervention Programs

By Ian G. Duncan · ACTEX Learning · 2014

Study guide: Exam GH-301

A textbook on the financial management and evaluation of healthcare intervention programs, which its publisher describes as the first textbook devoted to the subject. The second edition is in four parts: an introduction to care management interventions, actuarial issues in care management interventions, practical applications, and wellness, integrated programs and other new developments.

On the syllabus

  • Exam GH-301 — Disease Management; Ch. 3: Care Management Programs and Interventions (2a); Ch. 8: Understanding the Economics of Care Management Programs (2b); Ch. 9: Applying the Economic Model: The Example of Opportunity Analysis (2b); Ch. 11: The Use of Propensity Scoring in Program Evaluation (2b); Ch. 12: An Actuarial Method for Evaluating Care Management Outcomes, excluding Appendix 12.2-12.3 (2c); Ch. 13: Understanding Patient Risk and Its Impact on Chronic and Non-Chronic Member Trends (2d); Ch. 16: Testing Actuarial Methods for Evaluating Disease Management Savings Outcomes, excluding Appendices (2b).

Introduction to the Second Edition

Introduction to the First Edition

Acknowledgments

Part I An Introduction to Care Management Interventions

1 Introduction

  • 1.1 A Guide to the Contents of This Book
  • 1.2 The State of the Union
  • 1.3 What Has Changed?
  • 1.4 Where to From Here?
  • 1.5 What Have We Learned From Our Research
  • 1.6 A Change in Emphasis for Actuaries?

2 Clinical Background

  • 2.1 Introduction
  • 2.2 Diseases of Specific Body Systems
  • 2.3 Financial Implications of Disease
  • 2.4 Summary

3 Care Management Programs and Interventions

  • 3.1 Introduction
  • 3.2 Pre-Authorization
  • 3.3 Concurrent Review
  • 3.4 Case Management
  • 3.5 Demand Management
  • 3.6 Disease Management
  • 3.7 Specialty Case Management
  • 3.8 Population Health Management
  • 3.9 Care Coordination and Other Intervention Model Enhancements
  • 3.10 The Patient Centered Medical Home and Pay for Performance
  • 3.11 Accountable Care Organizations
  • 3.12 Non-Traditional Providers and Care Settings
  • 3.13 Gaps in Care and Quality Improvement Programs
  • 3.14 Telemedicine, Telehealth, and Automated Monitoring
  • 3.15 Bundled Payment Initiatives
  • 3.16 Conclusion

4 Actuarial Issues in Care Management Evaluations

  • 4.1 Introduction
  • 4.2 Measurement Principles
  • 4.3 Study Design Issues
  • 4.4 Risk Factors
  • 4.5 Conclusions
  • Appendix 4.1 Causality

5 Estimating Savings, Utilization Rate Changes and Return on Investment: A Selective Review of the Literature on Program Evaluation

  • 5.1 Introduction
  • 5.2 Searching the Health Care Literature
  • 5.3 Summary of Results: Original Study
  • 5.4 Current Study
  • 5.5 Conclusion

6 The Use of the Value Chain in Care Management Program Planning

  • 6.1 Introduction
  • 6.2 The CM Value Chain – Overview
  • 6.3 Components for Establishing Programs
  • 6.4 The Role of Value Chain Components in Program Design and Assessment
  • 6.5 Managing the Intervention Program using the Value Chain

7 Clinical Quality and its Measurement

  • 7.1 Introduction
  • 7.2 Layout of This Chapter
  • 7.3 The Challenge of Data Analysis for Quality Measurement
  • 7.4 Quality Organizations and Initiatives
  • 7.5 Categories of Measures
  • 7.6 Measurement Process
  • 7.7 Measurement Construction
  • 7.8 Consumer Assessment of Quality (HCAHPS)
  • 7.9 Application of Measures in Quality Improvement Initiatives
  • 7.10 Conclusion
  • Appendix 7.1 Summary of Quality Organizations and Measures
  • Appendix 7.2 CMS Performance Incentives
  • Appendix 7.3 Chronic Condition Clinical Performance Measures to be Tracked
  • Appendix 7.4 ACO Quality Performance Measures Required by CMS
  • Appendix 7.5 Medicare Part C & D and Medicare PDP Quality Performance Measures Required by CMS
  • Appendix 7.6 CMS HER Meaningful Use Measures (Stage 1)
  • Appendix 7.7 Surgical Care Improvement Program (SCIP)
  • Appendix 7.8 Consumer Assessment of Quality (HCAHPS)

Part II Actuarial Issues in Care Management Interventions

8 Understanding the Economics of Care Management Programs

  • 8.1 Introduction
  • 8.2 What is the Appropriate Financial Statistic to Measure?
  • 8.3 The Risk Management Economic Model
  • 8.4 Designing a Program
  • 8.5 Components of the Risk Management Economic Model
  • 8.6 Conclusion
  • Appendix 8.1 Calculating Return on Investment

9 Applying the Economic Model: The Example of Opportunity Analysis

  • 9.1 Introduction
  • 9.2 What is Opportunity Analysis?
  • 9.3 Member Stratification for Opportunity Analysis
  • 9.4 Designing a Program
  • 9.5 Implementing a Program
  • 9.6 The Value of Opportunity Analysis
  • 9.7 Conclusion

10 Measuring Care Management Savings Outcomes

  • 10.1 Introduction
  • 10.2 Evaluating a Savings Calculation
  • 10.3 Principles of Measurement Design: What Constitutes a Valid Methodology?
  • 10.4 Study Designs for DM: A Summary
  • 10.5 The Problem of Multiple Programs
  • 10.6 Conclusion

11 The Use of Propensity Scoring in Program Evaluation

  • 11.1 Introduction
  • 11.2 What is a Propensity Score?
  • 11.3 History of Propensity Score Matching
  • 11.4 General Approach to Propensity Score Matching
  • 11.5 Propensity Scores and Risk Adjustment
  • 11.6 Application of Propensity Score Matching to Diabetes Education
  • 11.7 Hypothesis
  • 11.8 Methods
  • 11.9 Results
  • 11.10 Conclusions

12 An Actuarial Method for Evaluating Care Management Outcomes

  • 12.1 Introduction
  • 12.2 The Actuarially-Adjusted Historical Control Methodology
  • 12.3 Practical Application of the Actuarially-Adjusted Historical Control Methodology
  • 12.4 Exposure
  • 12.5 Time Periods
  • 12.6 Chronic Members and Chronic Prevalence
  • 12.7 Results and Use
  • 12.8 Conclusion
  • Appendix 12.1 Members Excluded from Measurement
  • Appendix 12.2 Example of Claims Exclusion Criteria
  • Appendix 12.3 An Example of Member Classification over Time

13 Understanding Patient Risk and Its Impact on Chronic and Non-Chronic Member Trends

  • 13.1 Introduction
  • 13.2 Transition States and Their Effect on Equivalence and Trend
  • 13.3 Equivalence, Transition states, and Trend
  • 13.4 Practical Applications
  • 13.5 Results
  • 13.6 Applicability to Other Populations
  • 13.7 Conclusion

14 Random Fluctuations and Validity in Measuring Disease Management Effectiveness for Small Populations

  • 14.1 Introduction
  • 14.2 Methods
  • 14.3 Trends and Disease Management Savings Measurement
  • 14.4 The Base Measurement Method – Effect of Using Group-Specific Trend
  • 14.5 Alternate Measurement Method – Population Trend
  • 14.6 Alternate Measurement Method – Using Truncation to Stabilize Measurement
  • 14.7 Alternate Measurement Method – Utilization Measure
  • 14.8 Minimum Sample Sizes for Specific Diseases
  • 14.9 Practical Applications in Small Populations
  • 14.10 Limitations
  • 14.11 Conclusions
  • Appendix 14.1 Criteria used to Classify Members into Chronic Categories

Part III Practical Applications

15 A Comparative Analysis of Chronic and Non-Chronic Insured Commercial Membership Cost Trends

  • 15.1 Introduction
  • 15.2 Background
  • 15.3 Population and Methods
  • 15.4 Results
  • 15.5 Discussion
  • 15.6 Limitations
  • 15.7 Conclusions and Implications for Disease Management Purchasers
  • Appendix 15.1 Relationship Between Overall Trends and Trends of Sub-Groups

16 Testing Actuarial Methods for Evaluating Disease Management Savings Outcomes

  • 16.1 Introduction
  • 16.2 Background
  • 16.3 Methods
  • 16.4 Results
  • 16.5 Commercial HMO/POS Savings Calculation
  • 16.6 Discussion
  • 16.7 Conclusions
  • Appendix 16.1 Chronic Identification Criteria
  • Appendix 16.2 Check List of Issues/Assumptions for Conducting or Evaluating a Study

Part IV Wellness, Integrated Programs and Other New Developments in Care Management Programs

17 Introduction to Wellness and Integrated Programs

  • 17.1 Healthcare Expenditures
  • 17.2 Wellness, Health Promotion, and Disease Prevention
  • 17.3 Workplace Health
  • 17.4 Prevalence of Workplace Wellness Programs
  • 17.5 Health Risk and Risk Status
  • 17.6 Successful Wellness Programs
  • 17.7 Core Components of a Workplace Wellness Program
  • 17.8 Absenteeism, Presenteeism, and Productivity
  • 17.9 Integrated Programs
  • 17.10 Recent Developments in Wellness Programs
  • 17.11 Conclusion

18 Evaluation of Worksite Wellness Programs: Selective Review of the Literature

  • 18.1 Introduction
  • 18.2 Workplace Wellness Programs – The Literature
  • 18.3 Health Risk and Associated Medical Care Expenditure
  • 18.4 Financial Impact of Wellness Programs
  • 18.5 Risk Transition
  • 18.6 Health Risk and Productivity
  • 18.7 Health Related Productivity – Estimating Financial Impact
  • 18.8 Discussion of the Evidence
  • 18.9 Conclusion

19 The Relationship Between Health Risk Factors and Health Care Claims Cost in Program Design and Evaluation

  • 19.1 Introduction
  • 19.2 PART 1: Model Development
  • 19.3 Use of the Model for Intervention Program Planning
  • 19.4 Using the Model for Savings Estimation
  • 19.5 Application to Other Programs and Situations
  • Appendix 19.1 Risk Scores and Their Use in Our Models

Bibliography

Index

Sources